🇺🇸 FDA
Patent

US 7560265

Compositions for regulation of tumor necrosis factor-alpha

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7560265 (Compositions for regulation of tumor necrosis factor-alpha) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P1/04